跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Approved
THERAPEUTIC
CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Delpharm Montréal Inc. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 29, 2021
Approval ID
9102b5ca22d9bac6
Company
Delpharm Montréal Inc. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
9102b5ca22d9bac6
Drug Name
CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Product Name
CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Approval Number
SIN16091P
Approval Date
2021-01-29
Registrant
BAYER (SOUTH EAST ASIA) PTE LTD
Licence Holder
BAYER (SOUTH EAST ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R06AX13
Atc Item Name
loratadine
Pharma Manufacturer Name
BAYER (SOUTH EAST ASIA) PTE LTD
Active Ingredients
Loratadine
5 mg/ 5mL
LORATADINE
5 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 29, 2021
Approval ID
9102b5ca22d9bac6
Type
Therapeutic
Back to HSA Approvals
CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR) - HSA Drug Approval Details